ASH Clinical News ACN_4.12_Full book Web | Page 16

The Society Pages
Jonas Sokolof Appointed
Director of NYU Langone’s New
Rehabilitation Program for
Cancer Survivors
NYU Langone’s Rusk
Rehabilitation has opened
the Division of Oncological
Rehabilitation, launching
a new program to address
the rehabilitative needs of
people living with cancer.
Jonas M. Sokolof, DO
Jonas M. Sokolof, DO, was
appointed the center’s
director; he joins NYU Langone from Memo-
rial Sloan Kettering Cancer Center, where he
spent 10 years as an attending physician.
Working in conjunction with NYU Lan-
gone’s Perlmutter Cancer Center, the new
division will deliver individualized rehabilita-
tive care to patients during and following
cancer treatment, with the primary goal of
restoring their optimal function. Treatment
plans will incorporate rehabilitative services
like physical therapy, occupational therapy,
speech–language pathology and swallowing
therapy, vocational therapy, psychological
services, music and recreational therapy, nu-
trition counseling, and social work services.
Source: NYU Langone Health press release, May 31, 2018
Pershing Square Sohn
Announces Winners of 2018
Young Investigator Prize
The Pershing Square Sohn Cancer Research
Alliance announced the seven winners of the
2018 Pershing Square Sohn Prize for Young
Investigators in Cancer Research, including
immunotherapy and leukemia researchers.
The prize is awarded annually to early-career
investigators working in the New York City
area. Each winner receives $200,000 in
funding yearly for up to three years to pursue
explorative research.
Daniel Bachovchin,
PhD
Benjamin Greenbaum,
PhD
Indiana University Researcher
Receives NHLBI Outstanding
Investigator Award
Hal E. Broxmeyer, PhD, a
Distinguished Professor
at Indiana University (IU)
School of Medicine, received
a National Heart, Lung, and
Blood Institute (NHLBI)
Outstanding Investigator
Hal E. Broxmeyer, PhD
Award. This seven-year,
$5.4-million grant will fund
the continuation of Dr. Broxmeyer’s decades
of research into umbilical cord–blood trans-
plantation.
Dr. Broxmeyer and colleagues first pro-
posed the concept of using umbilical cord
blood as an alternative source of hematopoi-
etic cells for transplant in 1983. He and his
team also searched for ways around limi-
tations to the use of cord blood for trans-
plant, including collecting blood in a more
controlled environment with lower oxygen
levels, which could lead to more harvestable
cells.
Dr. Broxmeyer is a professor of microbiology
and immunology, the Mary Margaret Walther
Professor Emeritus, and chair emeritus of the
Department of Microbiology and Immunology
at IU. He also is a co-leader of the hemato-
poiesis and malignant-hematology research
program at the IU Melvin and Bren Simon
Cancer Center.
Source: Indiana University press release, July 18, 2018.
14
ASH Clinical News
Dan Landau, MD, PhD
• Daniel Bachovchin, PhD,
Memorial Sloan Kettering
Cancer Center, for his
work in determining the
mechanism of action
behind anti-cancer
protease inhibitors
• Benjamin Greenbaum,
PhD, Icahn School of
Medicine at Mount
Sinai, for his work in
analyzing complex data
to better understand
immunotherapy responses
• Dan Landau, MD, PhD,
Weill Cornell Medicine and
New York Genome Center,
for his work defining genetic
and nongenetic changes
that enable leukemia cells
to diversify and become
treatment-resistant.
Source: Pershing Square Sohn Cancer Research Alliance press release, May 22, 2018
Fran Paschall Appointed Chief
Nurse Executive for Cancer
Treatment Centers of America
Francine (Fran) Paschall,
MBA, DNP, RN, CENP, has
been named chief nurse ex-
ecutive of the Cancer Treat-
ment Centers of America,
a nationwide network of
hospitals and outpatient
Francine Paschall,
MBA, DNP, RN, CENP
care centers. In this role,
Ms. Paschall will pursue
strategies to enhance patient care, quality,
and safety. She also will represent the voice
of the nursing staff across the organization.
Ms. Paschall previously served as chief
nursing executive for Hospital Corporation of
America (HCA) East Florida Division. Earlier,
she was senior vice president of patient care
services/chief nursing officer for HCA’s River-
side Community Hospital in California.
“Providing powerful and innovative thera-
pies to heal the whole person, as well as pro-
viding hope and trust, are vital to care for our
“Nurses are central
to this commitment,
which is